Cancer-specific c-Myc mapping reveals overlooked SLK protein as treatment target

Дата публикации: 13-08-2026 20:40:05

Using a photochemically driven labeling technique, a Cornell-led research group has devised a strategy for capturing cancer-specific protein–protein interactions, which could one day lead to targeted therapies for prostate, small-cell lung, pancreatic and other deadly forms of cancer.

Основное содержимое страницы с новостью.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	Attacking cancer-enabling proteins where they live	0	18.95	13-08-2026
2	Experimental treatment kills prostate tumor cells while reawakening antitumor immunity	0	8.19	15-06-2026
3	Redesigned lung cancer drug matches tumor control with fewer off-target interactions	0	9.72	24-07-2026
4	A laser focus on melanoma	0	10	19-02-2026
5	New targeted therapy shows promising early results in advanced pancreatic cancer	2	7	05-07-2026
6	В РАН рассказали о борьбе с раком посредством клеток, помогающих опухоли расти	0	0	27-08-2019
7	New study reveals how blood cancers outsmart BTK-targeted therapies	0	8.1	28-07-2026
8	Researchers develop mathematical measures to better personalize therapy for prostate cancer	0	7.4	13-08-2026
9	Russian-Chinese Scientists Find Way to Treat 'Incurable' Type of Cancer	0	8.15	29-07-2026
10	Получено перспективное соединение для создания нового препарата против рака	0	0	24-02-2025

Классификация: Наука. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 17.95. Источник: medicalxpress.com.